Kyropan-D
Dual Release Protection Against Acid Reflux & Dyspepsia
Pantoprazole 40 mg & Domperidone SR 30 mg capsules
Detailed Formulation & Active Ingredients
Each hard gelatin capsule contains:
Pantoprazole Sodium (as enteric coated pellets) equivalent to Pantoprazole 40 mg
Domperidone (as sustained release pellets) 30 mg.
Therapeutic Indications & Clinical Scope
Gastroesophageal Reflux Disease (GERD), non-ulcer dyspepsia, diabetic gastroparesis, hyperacidity associated with nausea, and peptic ulcer disease.
Dosage & Administration
One capsule daily in the morning before food or as directed by the physician.
Notice: Dosage schedules should be tailored according to clinical assessment and physician direction.
Storage & Handling Guidelines
Store below 25°C in a dry place. Protect from light.
Overview & Compliance
Kyropan-D integrates potent proton pump inhibition from Pantoprazole with the prokinetic pro-motility action of sustained-release Domperidone. It eliminates burning acid reflux and controls nausea for sustained 24-hour relief.
Inquire About Kyropan-D
Fill in the form below and our medical affairs representative will follow up with complete technical and supply details.
Other Formulations in Our Range
Paradase
10x10 TabletsAceclofenac 100 mg, Paracetamol 325 mg, Serratiopeptidase 15 mg
Syrup Multisine
200 mlSyrup of B-complex and L-lysine
Kyrocep-CV
10x10 TabletsCefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg tablets